Home
Biomatters

Biomatters Market Share Analysis for January 2026

geneious prime is the world’s leading bioinformatics software platform for molecular biology and sequence analysis. enterprises involved in antibody discovery are choosing geneious biologics

Science and Education > Biology

Domainbiomatters.com

Year Founded--

Employees51 - 200

Annual Revenue$2M - $5M

Biomatters

Biomatters (including company regionals)

biomatters.com

See more website traffic and engagement information

Biomatters Revenue up to January 2026 is 2M - 5M

revenue generated by Biomatters top domains

Biomatters top domains revenue over 3 years

Revenue for Biomatters top domains

biomatters.com2M - 5M

See more with Sales Intelligence

Total visits to Biomatters's top domains

Understand Biomatters market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Biomatters's top domains

Analyze Biomatters engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Biomatters's top domains

See how Biomatters keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Biomatters top competitors by domain

Top similar sites in January 2026, ranked by their affinity

geneious.comCompany NameGeneiousEmployees501 - 1000HQNew Zealand, AucklandAnnual revenue< $1MTotal visits109.1KScience and Education > Biology

Top technologies used by Biomatters

These are the website technologies, by industry, used by Biomatters top domains

Conversion & Analytics (5)

Google Analytics

Advertising (4)

DoubleClick

Email Services (3)

G Suite

Social (3)

Twitter

More Technologies

13

See all

News & Signals from Biomatters

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsGraphPad Software, Inc. acquired Biomatters Ltd. on Apr 25th '19.GraphPad, a leading provider of data analysis and visualization software for the life sciences industry, announced today that it will acquire Biomatters, a leading provider of Geneious DNA data analysis solutions.

NewsBiomatters Ltd. launched Geneious Prime 2019 on Nov 8th '18.Biomatters is proud to announce the release of Geneious Prime 2019 today with a variety of features including significantly enhanced capability for primer design, an essential part of cloning operations in commercial organizations.

NewsGeneious integrates with Biomatters Ltd..Geneious Biologics integrates with Biomatters' existing Geneious DNA analysis tools and leverages the company's deep expertise in delivering solutions that meet customers' real-life needs.